Estimating the Global Burden of Diarrheal Diseases
Supports teams producing country-level estimates of major diarrheal diseases to inform global health planning and child health priorities.
The Bill and Melinda Gates Foundation's Grand Challenges initiative issued an RFP titled "Estimating the Global Burden of Diarrheal Diseases" to fund high-quality research generating country-specific disease burden estimates for 2025. The challenge is housed under the Grand Challenges platform and administered through the Foundation's grant portal at submit.gatesfoundation.org. Applications were d…
Research generating minimum country-specific 2025 burden estimates for eight diarrheal pathogens — rotavirus, Shigella, adenovirus, norovirus, ST-ETEC, cholera, Cryptosporidium, and Campylobacter — with emphasis on under-five child mortality in LMICs.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
BudgetBudget Narrative Example for Grant Proposals
See how to write a grant budget narrative with line-item examples, a template structure, weak vs strong wording, and reviewer-facing cost logic.
More from Gates Foundation
All grants from this funder →Gates Foundation Grand Challenges — Portfolio
Gates Foundation · United States
Supports global health innovators through rotating challenge themes in diagnostics, nutrition, and development-focused technologies for public impact.
Grand Challenges — Breakthrough Innovations to Reduce the Cost of Severe Acute Malnutrition Treatment
Gates Foundation · United States
Funds global teams developing system-level innovations that reduce the total cost of treating severe acute malnutrition in Sub-Saharan Africa and South Asia.
Grand Challenges — Cost-Reducing Innovations for Ready-to-Use Therapeutic Food
Gates Foundation · United States
Funds global teams developing innovations in protein, lipids, packaging, and manufacturing that reduce the ex-factory unit cost of ready-to-use therapeutic food by at least 30%.
Grand Challenges — Placental and Gut Inflammation Interventions for Fetal Growth
Gates Foundation · United States
Funds global teams developing drug, biologic, dietary, or microbiome-based interventions that target placental and gut inflammatory pathways to improve fetal growth outcomes in low-income countries.
Grand Challenges — Ultralow-Cost Diagnostics and Screening for Low-Income Countries
Gates Foundation · United States
Funds global teams developing diagnostic devices and screening tools that cost approximately $1 per test or near-zero incremental cost per person screened for deployment in low-income countries.
Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows
Gates Foundation · United States
Funds research teams building low-cost, simplified pathogen-sequencing workflows that bring the cost of sequencing a sample down to about US$1-10 for use in low- and middle-income countries.
Similar grants
Browse the directory →
Decode the Immunoscience of age-related diseases
🇪🇺IHI JU · European Union
Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.
Prevention and management of chronic non-communicable diseases in children and young people
🇪🇺European Commission · European Union
Funds implementation research that helps children and young people prevent and manage chronic disease equitably.
Innovative healthcare interventions for non-communicable diseases
🇪🇺European Commission · European Union
Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.
AI Predictive Biomarkers for Chronic Diseases
🇪🇺European Commission · European Union
Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
🇺🇸NIH · United States
Funds an investigator's own phase I trial in heart, lung, blood or sleep disease — with every regulatory approval already in hand at award.
Portable and versatile Point-of-care diagnostics
🇪🇺European Commission · European Union
Funds €5–7M projects that make point-of-care diagnostics more portable, versatile, accurate and useful in clinical practice.